Medications

54 bookmarks
Custom sorting
Latuda: 7 things you should know - Drugs.com
Latuda: 7 things you should know - Drugs.com
Quick easy-to-read overview of Latuda. Includes: how it works, upsides, downsides, bottom line, tips, response and effectiveness.
·drugs.com·
Latuda: 7 things you should know - Drugs.com
Antipsychotics and Anxiolytics
Antipsychotics and Anxiolytics
Central nervous system (CNS) depressants used to manage symptoms of psychosis and anxiety disorders include antipsychotics and anxiolytics, which may cause psychosis. Antipsychotics are also…
All antipsychotics block the D2 (dopaminergic) receptor, which in turn promotes the presence of EPS, resulting in drug-induced pseudoparkinsonism in varying degrees.
All antipsychotics block the D2 (dopaminergic) receptor, which in turn promotes the presence of EPS, resulting in drug-induced pseudoparkinsonism in varying degrees
they block the serotonin receptor.
Pseudoparkinsonism, which resembles symptoms of parkinsonism, is a major side effect of typical antipsychotic drugs.
stooped posture, masklike facies, rigidity, tremors at rest, shuffling gait, pill-rolling motions of the hands
·basicmedicalkey.com·
Antipsychotics and Anxiolytics
Oral Fenbendazole for Cancer Therapy in Humans and Animals
Oral Fenbendazole for Cancer Therapy in Humans and Animals
Fenbendazole is a benzimidazole anthelmintic agent commonly used to treat animal parasitic infections. In humans, other benzimidazoles, such as mebendazole and albendazole, are used as antiparasitic agents. Since fenbendazole is not currently approved by the FDA or EMA, its pharmacokinetics and safety in humans have yet to be well-documented in medical literature. Despite this, insights can be drawn from existing in vitro and in vivo animal studies on its pharmacokinetics. Given the low cost of fenbendazole, its high safety profile, accessibility, and unique anti-proliferative activities, fenbendazole would be the preferred benzimidazole compound to treat cancer. To ensure patient safety in the repurposing use of fenbendazole, it is crucial to perform clinical trials to assess its potential anticancer effects, optimal doses, therapeutic regimen, and tolerance profiles. This review focuses on the pharmacokinetics of orally administered fenbendazole and its promising anticancer biological activities, such as inhibiting glycolysis, down-regulating glucose uptake, inducing oxidative stress, and enhancing apoptosis in published experimental studies. Additionally, we evaluated the toxicity profile of fenbendazole and discussed possibilities for improving the bioavailability of the drug, enhancing its efficacy, and reducing potential toxicity.
·ar.iiarjournals.org·
Oral Fenbendazole for Cancer Therapy in Humans and Animals
Abilify and losartan Interactions Checker - Drugs.com
Abilify and losartan Interactions Checker - Drugs.com
ARIPiprazole and losartan may have additive effects in lowering your blood pressure.
ARIPiprazole and losartan may have additive effects in lowering your blood pressure.
when treatment is restarted after an interruption
over-the-counter potassium supplements
·drugs.com·
Abilify and losartan Interactions Checker - Drugs.com
Lab%20 work%20 pharmacist%20 letter
Lab%20 work%20 pharmacist%20 letter
!!!! Contraindicated in renal insufficiency (serum creatinine 1.5 mg/dL in men or abnormal creatinine clearance
·mysccg.com·
Lab%20 work%20 pharmacist%20 letter
Cholinesterase Inhibitors: Alzheimer's Uses, Side Effects
Cholinesterase Inhibitors: Alzheimer's Uses, Side Effects
Cholinesterase inhibitors are drugs that prevent the breakdown of acetylcholine, and blocks the action of acetylcholinesterase in the body. Researchers believe that decreased levels of acetylcholine in the brain causes Alzheimer's disease symptoms. Common side effects of cholinesterase inhibitors are insomnia, abnormal dreams, weight loss, headache, nausea, vomiting, diarrhea, confusion, and fatigue.
·medicinenet.com·
Cholinesterase Inhibitors: Alzheimer's Uses, Side Effects
Venlafaxine monograph
Venlafaxine monograph
~Venlafaxine and ODV have no significant affinity for muscarinic, ~Aggression may occur in some patients who have received antidepressants, including venlafaxine treatment, dose reduction, or discontinuation ~aggression have been observed in patients during changes in venlafaxine dosing regimen, including during discontinuation ~Discontinuation.. symptoms include aggression, agitation,
·pdf.hres.ca·
Venlafaxine monograph
Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
Cholinergic transmission at muscarinic acetylcholine receptors (mAChR) has been implicated in higher brain functions such as learning and memory, and loss of synapses may contribute to the symptoms of Alzheimer disease. A heterogeneous family of ...
·pmc.ncbi.nlm.nih.gov·
Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Cognitive impairment is a core symptom of schizophrenia and a major determinant of poor long-term functional outcomes. Despite considerable efforts, we do not yet have any approved pharmacological treatments for cognitive impairment associated with ...
·pmc.ncbi.nlm.nih.gov·
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Dementia with Lewy bodies - Wikipedia
Dementia with Lewy bodies - Wikipedia
Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. Memory loss is not always an early symptom. The disease worsens over time and is usually diagnosed when cognitive impairment interferes with normal daily functioning. Together with Parkinson's disease dementia, DLB is one of the two Lewy body dementias. It is a common form of dementia, but the prevalence is not known accurately and many diagnoses are missed. The disease was first described on autopsy by Kenji Kosaka in 1976, and he named the condition several years later.
·en.wikipedia.org·
Dementia with Lewy bodies - Wikipedia
Aripiprazole Side Effects: Common, Severe, Long Term
Aripiprazole Side Effects: Common, Severe, Long Term
Learn about the side effects of aripiprazole, from common to rare, for consumers and healthcare professionals.
jerking, or stiffness
restlessness
shuffling walk
stiffness of the limbs
difficulty with speaking drooling loss of balance control
loss of bladder control
·drugs.com·
Aripiprazole Side Effects: Common, Severe, Long Term
Five Things You Didn't Know About Antibiotics and Your Brain
Five Things You Didn't Know About Antibiotics and Your Brain
Yes, antibiotics are miracle drugs, but they have some quirks. Among them are unexpected interactions with the brain. Here are five surprising connections.
·psychologytoday.com·
Five Things You Didn't Know About Antibiotics and Your Brain
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
"patients in treatment of RCDI and regularly encountered post-FMT re-infections with C. difficile following uncomplicated UTI treatment with all commonly used oral antibiotics, including quinolones, penicillins, cephalosporins, macrolides, sulfamethoxazole/trimethoprim, nitrofurantoin and fosfomycin"
patients in treatment of RCDI and regularly encountered post-FMT re-infections with C. difficile following uncomplicated UTI treatment with all commonly used oral antibiotics, including quinolones, penicillins, cephalosporins, macrolides, sulfamethoxazole/trimethoprim, nitrofurantoin and fosfomycin
she had not had a UTI episode for over 3 months
regimen of methenamine hippurate and ascorbic acid
positive test for C. difficile
while on vancomycin
discharged after 3 days of treatment with amikacin
·ncbi.nlm.nih.gov·
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection